MSD International GmbH (Singapore Branch) – FDA 483

MSD International GmbH (Singapore Branch), an API manufacturer, was cited for six observations during an FDA inspection. The findings primarily concern significant deficiencies in data review procedures, process validation, computer system controls, complaint investigations, cleaning procedures, and microbiological testing methods. These issues indicate a lack of robust quality control and data integrity practices.